All In Biotech

Drug Trial Radar · NCT01106014

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension

Last checked: Nov 20, 2026Latest source record: Oct 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,156 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,156

Actual

Start

Dec 1, 2009

Primary completion

Apr 1, 2014

Study completion Oct 1, 2014

Sponsor

Lead sponsor
ActelionJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 19, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The AC-065A302 (GRIPHON) study is an event-driven Phase 3 study to demonstrate the effect of selexipag on time to first morbidity or mortality event in patients with pulmonary arterial hypertension.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • SelexipagDrug

    Selexipag 200 µg tablets

  • PlaceboDrug

    Placebo tablets matching selexipag

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time From Randomization to the First Morbidity Event or Death (All Causes) up to 7 Days After the Last Study Drug IntakeTime frame: Up to 7 days after end of double-blind treatment (maximum: 4.3 years)

Locations

182 sites in 39 countries. Site status is shown where the registry gives one.

  • University of South Alabama

    Mobile, Alabama

  • The University of Arizona, Clinical and Translational Science (CATS) Research Center

    Tucson, Arizona

  • University of California San Diego Medical Center (La Jolla)

    La Jolla, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • GLVA Healthcare Center

    Los Angeles, California

  • University of California, Davis, UC Davis Medical Center

    Sacramento, California

  • LIU Center for Pulmonary Hypertension

    Torrance, California

  • Lung Health & Sleep Emhancement Center, LLC

    Newark, Delaware

  • Emory University School of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine

    Atlanta, Georgia

  • Georgia Health Sciences University

    Augusta, Georgia

  • Georgia Clinical Research

    Austell, Georgia

  • Clarian North Hospital

    Carmel, Indiana

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa

  • Kentuckiana Pulmonary Associates

    Louisville, Kentucky

  • LSU Health Science Center - New Orleans

    New Orleans, Louisiana

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

  • Massachusetts General Hospital - Pulmonary Critical Care Unit

    Boston, Massachusetts

  • Massachusetts General Hospital-Pulmonary Critical Care Unit

    Boston, Massachusetts

  • Boston University School of Medicine / Boston University Medical Center

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • Beaumont Hospital

    Troy, Michigan

  • Washington University School of Medicine

    St Louis, Missouri

  • Newark Beth Isreal Medical Center-Department of Pulmonary Medicine

    Newark, New Jersey

  • Columbia University Medical Center, Pediatric Cardiology

    New York, New York

  • Montefiore Medical Center, Weiler Division

    The Bronx, New York

  • Duke University Medical Center

    Durham, North Carolina

  • The Lindner Clinical Trial Center

    Cincinnati, Ohio

  • University of Cincinnati

    Cincinnati, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • The Ohio State University Medical Center

    Columbus, Ohio

  • Oregon Pulmonary Associates, PC

    Portland, Oregon

  • Central Bucks Specialists

    Doylestown, Pennsylvania

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Vanderbilt Medical Center

    Nashville, Tennessee

  • UT Southwestern Medical Center at Dallas

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • University of Texas-Houston Health Center Department of Pulmonary & Critical Care

    Houston, Texas

Showing 40 of 182 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.